Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/01/1991 | CA2028603A1 13-epi-avermectin derivatives useful as antiparasitic agents |
05/01/1991 | CA2028496A1 Thiophene compounds and their pharmaceutical uses |
05/01/1991 | CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor |
05/01/1991 | CA2025189A1 Method for using (2-imidazolin-2-ylamino)quinoxalines to reduce or maintain intraocular pressure |
05/01/1991 | CA2001946A1 Process for the treatment of the skin to alleviate skin diseases arising from contact sensitization or irritation utilizing p-substituted phenoxy alkanols |
04/30/1991 | US5011973 Reacting A Trimethylammonium Salt With A Naphthalenedisulfonic Acid; Useful For Enhancing The Digestive Function |
04/30/1991 | US5011959 1,2-diaminocyclohexane-platinum complexes with antitumor activity |
04/30/1991 | US5011931 Process for the preparation of 1-methyl-3-methylthio-4-quinolone and the sulfinyl, and sulfonyl analogs thereof |
04/30/1991 | US5011930 Antilipemic agents, anticoagulants |
04/30/1991 | US5011929 From protected azidolactone by reduction and cyclization |
04/30/1991 | US5011928 Analgesic and antiinflammatory derivatives of 1-acyl-4-arylalkylpiperazines |
04/30/1991 | US5011859 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
04/30/1991 | US5011858 Therapy with coenzyme Q10 of patients having AIDS or other retroviral diseases |
04/30/1991 | US5011857 Administering 2,4-di-isobutyl-6-(n,n-dimethylaminomethyl)-phenol; antiinflammatory agent, alleviating psoriasis, diabetes, atheroschlerosis |
04/30/1991 | US5011856 Side effect reduction |
04/30/1991 | US5011855 Oil extracted from pips of Ribes genus fruits |
04/30/1991 | US5011853 Compounds for treatment of cholinergic neurotoxins |
04/30/1991 | US5011852 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
04/30/1991 | US5011850 Substituted diazolylalkyl-carbinols, a process for their preparation and their use as antimycotic agents |
04/30/1991 | US5011849 Monoamine oxidase inhibitors |
04/30/1991 | US5011848 Cardiovascular disorders, hypotensive agents |
04/30/1991 | US5011847 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
04/30/1991 | US5011846 Anxiolytic and hypotensive agent, gastric motility stimulant, for glucoma treatment |
04/30/1991 | US5011844 Substituted 4-azatricyclo(22.3.1.04,9)octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them |
04/30/1991 | US5011843 Treatment of glaucoma using phosphodiesterase inhibitors |
04/30/1991 | US5011842 2-(heterocyclylalkyl)imidazopyridines for treating allergic diseases |
04/30/1991 | US5011841 4,7-methanoisoindole derivative |
04/30/1991 | US5011840 Imidazolidinedione derivatives in diabetes treatment |
04/30/1991 | US5011839 3(2H)pyridazinones for antagonistic agent against srs-a |
04/30/1991 | US5011838 Antiallergens, antihistamines |
04/30/1991 | US5011837 Aryl cyanoguanidines: potassium channel activators and method of making same |
04/30/1991 | US5011836 Dibenz(b,e)azepin-6-one derivatives |
04/30/1991 | US5011835 Substituted triazolopyridazines, pharmaceutical compositions and use |
04/30/1991 | US5011834 PCP receptor ligands and the use thereof |
04/30/1991 | US5011833 Novel derivatives of 6,11-dihydro-dibenzo(C,F)(1,2,5)-thiadiazepine 5,5-dioxide, salts thereof and appropriate processes for the preparation thereof |
04/30/1991 | US5011829 Pharmaceutical composition and method of inhibiting virus |
04/30/1991 | US5011828 Immunostimulating guanine derivatives, compositions and methods |
04/30/1991 | US5011827 Elaiophyline derivatives, compositions containing them and the use thereof as anthelmintic agents |
04/30/1991 | US5011695 Sterilization of blood and its derivatives with vitamins |
04/30/1991 | US5011682 Hypophosphite-containing cotelomers as antitartar agents |
04/30/1991 | CA1283750C Platinum co-ordination compounds |
04/30/1991 | CA1283661C Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates |
04/30/1991 | CA1283659C Carbapenem antibiotics |
04/30/1991 | CA1283658C Process for quinoline-3-carboxylic acid antibacterial agents |
04/30/1991 | CA1283657C 1,5-benzothiazepine derivatives, their preparation and compositions containing them |
04/30/1991 | CA1283656C Deoxyadenosine phosphate compounds and methods of making and using the same |
04/30/1991 | CA1283607C Stable injectable pharmaceutical formulation for 1,4- dihydroxy-5-8-bis¬2-(2-hydroxyethylamino)-ethylamino| anthraquinone, dihydrochloride |
04/30/1991 | CA1283605C Pharmaceutical composition for suppository containing buprenorphine |
04/30/1991 | CA1283604C2 Dehydrated liposomes |
04/28/1991 | WO1991006561A1 Method for treating hiv and other retroviruses and compounds useful therefor |
04/28/1991 | WO1991006539A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | WO1991006538A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | WO1991006537A2 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | WO1991006303A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
04/28/1991 | CA2071898A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
04/28/1991 | CA2070422A1 Substituted indole-, indene-, pyranoindole and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2067138A1 Substituted benzoylbenzene-, biphenyl-and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2067135A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase |
04/28/1991 | CA2066644A1 Method for treating hiv and other retroviruses and compounds useful therefor |
04/28/1991 | CA2028648A1 Process for preparing azt (azido-3'-deoxy-3'-thymidine) and related compounds |
04/28/1991 | CA2028645A1 Use of arylalkylamides in the treatment of neurodegenerative diseases |
04/28/1991 | CA2028633A1 Sustained-release preparation of basic medical agent hydrochloride |
04/28/1991 | CA2028538A1 4-substituted isoquinolone derivatives, their production and use |
04/28/1991 | CA2028536A1 Injectable parasiticidal composition |
04/27/1991 | WO1991006302A1 Ribozyme inhibitors |
04/27/1991 | CA2071534A1 Ribozyme inhibitors |
04/27/1991 | CA2028394A1 Dihydropyridine derivatives and pharmaceutical compositions |
04/26/1991 | WO1991006542A1 Pharmaceutically active amino-substituted heteroaryl amines |
04/26/1991 | WO1991006536A1 Method of inhibiting the transport of l-glutamate |
04/26/1991 | CA2069912A1 Method of inhibiting the transport of l-glutamate |
04/26/1991 | CA2065305A1 Pharmaceutically active amino-substituted heteroaryl amines |
04/26/1991 | CA2028610A1 Triazolo derivatives and process for their preparation |
04/26/1991 | CA2028557A1 Triazolyl hydrazide derivatives and process for their preparation |
04/26/1991 | CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas |
04/26/1991 | CA2027937A1 Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles |
04/25/1991 | WO1991006296A1 Bafilomycine macrolides for treatment of bone affecting diseases |
04/25/1991 | DE3935066A1 Treatment of prophylaxis of polio and herpes virus infections - comprises admin. of 3-(di:hydro-5-(hydroxy-1H- indolyl-2-oxo-3H-pyrrolidene)-di:hydro-2H-indole |
04/25/1991 | CA2071914A1 Bafilomycine macrolides for treatment of bone affecting diseases |
04/25/1991 | CA2028326A1 Furosemide salts, process for the preparation thereof, application as medicaments and pharmaceutical compositions containing them |
04/25/1991 | CA2028307A1 Cosmetic and pharmaceutic compositions containing reticulated poly-.beta-alanine spheres impregnated with a lipophilic substance |
04/25/1991 | CA2028285A1 Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments |
04/24/1991 | WO1991005556A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
04/24/1991 | WO1991005554A1 Carnitine supplemented cat fish diet |
04/24/1991 | EP0424350A1 Derivatives of 1,4-dideoxy-1,4-imino-d-mannitol |
04/24/1991 | EP0424349A1 Synthesis of 1,4-dideoxy-1,4-imino-D-mannitol |
04/24/1991 | EP0424317A2 Pyrimidines |
04/24/1991 | EP0424315A2 Tetracyclic pyrrole lactam derivatives |
04/24/1991 | EP0424248A2 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them |
04/24/1991 | EP0424244A1 3-Aryl oxazolidinone derivatives, their preparation and their therapeutical use |
04/24/1991 | EP0424243A1 3-Aryl oxazolidinones, process for their preparation and their therapeutical use |
04/24/1991 | EP0424214A1 5-[2-[[2-Amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5H)-benzothiazepine-4-one derivatives, their preparation and their use in therapy |
04/24/1991 | EP0424195A1 Imidazoles |
04/24/1991 | EP0424194A2 Benzanilide derivatives and their use as anti-atherosclerotic agents |
04/24/1991 | EP0424193A2 Use of actinonin for the manufacture of a medicament for angiogenesis inhibition |
04/24/1991 | EP0424179A2 Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
04/24/1991 | EP0424156A2 Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
04/24/1991 | EP0424059A1 Use of sustituted imidazoles for the manufacture of an analgesic |
04/24/1991 | EP0424043A1 Liquid aqueous ophthalmic composition undergoing liquid-gel phase transition |
04/24/1991 | EP0424028A2 S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics |
04/24/1991 | EP0424021A1 Antimuscarinic bronchodilators |